ITP Stock Analysis: Interparfums | PA
Household & Personal Products | PA, France | Market Cap: 2.626m EUR | 12M Return: 14.6% | FR0004024222 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.15M
Rev. Trend: 95.6%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Interparfums SA is a French company that manufactures and sells perfumes and cosmetics across global markets, including Western and Eastern Europe, North America, South America, Asia, the Middle East, and Africa. The company also handles the purchase, manufacture, import, and export of related fashion products. Founded in 1982 and headquartered in Paris, Interparfums operates as a subsidiary of Interparfums Inc. (ticker: ITP).
The companys brand portfolio spans a range of well-known luxury and fashion names, including Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas, and Van Cleef & Arpels. Interparfums is classified within the Consumer Staples sector under the Personal Care Products sub-industry.
Interparfums operates primarily under a fragrance licensing business model, in which it develops, produces, and distributes perfumes for fashion and luxury houses that retain ownership of their brand names. This licensing approach allows the company to manage a diversified portfolio of premium brands without bearing the costs of brand building, while generating revenue through royalties and product sales. The global fragrance industry is a relatively defensive segment of consumer staples, supported by steady demand for prestige beauty products.
- Coach and Jimmy Choo fragrances drive North America revenue growth
- China luxury demand weakness pressures Asia fragrance sales volumes
- New Moncler and Van Cleef licenses expand premium brand portfolio
| Net Income: 118.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 5.64 > 1.0 |
| NWC/Revenue: 41.72% < 20% (prev 40.02%; Δ 1.70% < -1%) |
| CFO/TA 0.18 > 3% & CFO 172.0m > Net Income 118.9m |
| Net Debt (23.2m) to EBITDA (191.0m): 0.12 < 3 |
| Current Ratio: 3.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.9m) vs 12m ago 15.71% < -2% |
| Gross Margin: 64.64% > 18% (prev 65.75%; Δ -1.11% > 0.5%) |
| Asset Turnover: 88.04% > 50% (prev 91.17%; Δ -3.13% > 0%) |
| Interest Coverage Ratio: 4.64 > 6 (EBIT TTM 158.4m / Interest Expense TTM 34.2m) |
| A: 0.37 (Total Current Assets 530.0m - Total Current Liabilities 168.4m) / Total Assets 976.5m |
| B: 0.46 (Retained Earnings 448.8m / Total Assets 976.5m) |
| C: 0.16 (EBIT TTM 158.4m / Avg Total Assets 984.5m) |
| D: 2.68 (Book Value of Equity 709.7m / Total Liabilities 265.3m) |
| Altman-Z'' = 7.82 = AAA |
| DSRI: 1.13 (Receivables 196.7m/181.1m, Revenue 866.7m/904.8m) |
| GMI: 1.02 (GM 65.75% / 64.64%) |
| AQI: 0.98 (AQ_t 0.29 / AQ_t-1 0.29) |
| SGI: 0.96 (Revenue 866.7m / 904.8m) |
| TATA: -0.05 (NI 118.9m - CFO 172.0m) / TA 976.5m) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of September 27, 2026, the stock is trading at EUR 30.38 with a total of 46,455 shares traded. Over the past week, the price has changed by +4.47%, over one month by +11.04%, over three months by +24.22% and over the past year by +14.61%.
Current recommended Stop Loss: 28.80 (which is 5.2% or 2.2 ATR below the current price).
Interparfums has no consensus analysts rating.
P/E Trailing = 22.4812
P/E Forward = 18.7617
P/S = 3.03
P/B = 3.5988
P/EG = 2.8117
Revenue TTM = 866.7m EUR
EBIT TTM = 158.4m EUR
EBITDA TTM = 191.0m EUR
Long Term Debt = 79.1m EUR (from longTermDebt, last quarter)
Short Term Debt = 42.5m EUR (from shortTermDebt, last quarter)
Debt = 138.2m EUR (from shortLongTermDebtTotal, last quarter) + Leases 9.97m
Net Debt = 23.2m EUR (calculated: Debt 138.2m - CCE 114.9m)
Enterprise Value = 2.65b EUR (2.63b + Debt 138.2m - CCE 114.9m)
Interest Coverage Ratio = 4.64 (Ebit TTM 158.4m / Interest Expense TTM 34.2m)
EV/FCF = 15.97x (Enterprise Value 2.65b / FCF TTM 165.9m)
FCF Yield = 6.26% (FCF TTM 165.9m / Enterprise Value 2.65b)
FCF Margin = 19.14% (FCF TTM 165.9m / Revenue TTM 866.7m)
Net Margin = 13.72% (Net Income TTM 118.9m / Revenue TTM 866.7m)
Gross Margin = 64.64% ((Revenue TTM 866.7m - Cost of Revenue TTM 306.5m) / Revenue TTM)
Gross Margin QoQ = 65.43% (prev 63.92%)
Tobins Q-Ratio = 2.71 (Enterprise Value 2.65b / Total Assets 976.5m)
Interest Expense / Debt = 24.73% (Interest Expense 34.2m / Debt 138.2m)
Taxrate = 23.75% (37.1m / 156.3m)
NOPAT = 120.8m (EBIT 158.4m * (1 - 23.75%))
Current Ratio = 3.15 (Total Current Assets 530.0m / Total Current Liabilities 168.4m)
Debt / Equity = 0.19 (Debt 138.2m / totalStockholderEquity, last quarter 709.7m)
Debt / EBITDA = 0.12 (Net Debt 23.2m / EBITDA 191.0m)
Debt / FCF = 0.14 (Net Debt 23.2m / FCF TTM 165.9m)
Total Stockholder Equity = 704.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.08% (Net Income 118.9m / Total Assets 976.5m)
RoE = 16.89% (Net Income TTM 118.9m / Total Stockholder Equity 704.1m)
RoCE = 20.23% (EBIT 158.4m / Capital Employed (Equity 704.1m + L.T.Debt 79.1m))
RoIC = 14.97% (NOPAT 120.8m / Invested Capital 807.2m)
WACC = 8.19% (E(2.63b)/V(2.76b) * Re(7.63%) + D(138.2m)/V(2.76b) * Rd(24.73%) * (1-Tc(0.24)))
Discount Rate = 7.63% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 69.68 | Cagr: 6.65%
[DCF] Terminal Value 77.97% ; FCFF base≈144.6m ; Y1≈165.7m ; Y5≈243.9m
[DCF] Fair Price = 41.52 (EV 3.67b - Net Debt 23.2m = Equity 3.65b / Shares 87.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
Revenue Correlation: 95.65 | Revenue CAGR: 23.39% | SUE: 1.05 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=1.34 | Chg30d=+1.94% | Revisions=+18% | GrowthEPS=-10.8% | GrowthRev=-4.5%
EPS next Year (2027-12-31): EPS=1.43 | Chg30d=+0.91% | Revisions=-10% | GrowthEPS=+6.2% | GrowthRev=+9.0%
[Analyst] Revisions Ratio: +6% (up=8, down=7)